KAIROS PHARMA, LTD. (KAPA) Operating cash flow 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.4MFY2025 · since FY2023: $81,000 → -$3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.4M | +13.0% |
| FY2024 | -$4.0M | -4982.7% |
| FY2023 | $81,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KAPA financial trends
KAPA RevenueKAPA Net incomeKAPA Net marginKAPA Gross profitKAPA Gross marginKAPA Operating incomeKAPA Operating marginKAPA Free cash flowKAPA Capital expendituresKAPA Return on equityKAPA Stock buybacksKAPA Dividends paidKAPA Total assetsKAPA Total liabilitiesKAPA Shareholders’ equityKAPA overview →